SB

Samsara BioCapital Portfolio holdings

AUM $969M
1-Year Est. Return 134.49%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+134.49%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$761M
AUM Growth
+$264M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
49
New
Increased
Reduced
Closed

Top Buys

1
+$185M
2
+$36.1M
3
+$28.7M
4
RXRX icon
Recursion Pharmaceuticals
RXRX
+$23M
5
JANX icon
Janux Therapeutics
JANX
+$13.5M

Top Sells

1
+$8.72M
2
+$5.19M
3
+$3.55M
4
VTGN icon
VistaGen Therapeutics
VTGN
+$2.71M
5
KRON
Kronos Bio
KRON
+$2.23M

Sector Composition

1 Healthcare 98.51%
2 Financials 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$228M 30.02%
+1,061,660
2
$64.5M 8.48%
2,034,703
3
$44.7M 5.88%
3,168,388
4
$41.4M 5.45%
107,270
+29,569
5
$39M 5.12%
1,565,529
6
$34.1M 4.49%
+1,537,533
7
$31.1M 4.09%
167,558
8
$28.3M 3.72%
+775,583
9
$25.4M 3.34%
+1,637,308
10
$15.2M 1.99%
+607,949
11
$14M 1.84%
169,852
12
$13.9M 1.83%
794,171
-228,441
13
$13.4M 1.76%
2,125,371
-247,105
14
$12.8M 1.68%
640,688
15
$12.7M 1.66%
+932,239
16
$12.5M 1.64%
146,259
17
$11.4M 1.5%
36,873
18
$10.6M 1.39%
218,920
19
$8.06M 1.06%
711,039
-120,586
20
$7.27M 0.96%
1,111,112
21
$7.11M 0.93%
826,422
22
$6.4M 0.84%
30,160
23
$6.15M 0.81%
35,349
24
$5.88M 0.77%
300,293
+99,247
25
$5.69M 0.75%
500,000
1
2